In reply to letter to editor regarding ``a multicenter, randomised, double-blind, imipenem/cilastatin-controlled clinical study of cefiderocol for the treatment of complicated urinary tract infections caused by Gram-negative pathogens in Chinese adults''

International Journal of Antimicrobial Agents · Elsevier

Аннотация

Publication date: December 2026 Source: International Journal of Antimicrobial Agents, Volume 67, Issue 12 Author(s): Jinyi Yuan, Deyong Fan, Henglan Wu, Bei Jia, Takamichi Baba, Takuhiro Sonoyama, Honghong Dou, Ningning Xie, Tao Gu, Haihui Huang, Yingyuan Zhang

Читать у издателя →

Похожие статьи